Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Sodium (S) - lactate ; Sodium chloride; Potassium chloride; Calcium chloride dihydrate
Dechra Regulatory B.V.
QB05BB01
Sodium (S) - lactate ; Sodium chloride; Potassium chloride; Calcium chloride dihydrate
3.2, 6, 0.4, 0.2 milligram(s)/millilitre
Solution for infusion
POM: Prescription Only Medicine as defined in relevant national legislation
electrolytes
Authorised
2013-08-09
1 _[Version 8, 10/2012] _ _ _ ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE VETERINARY MEDICINAL PRODUCT VETIVEX 11 (Hartmann’s) solution for infusion for cattle, horses, dogs and cats [UK, IE] VETIVEX Ringer Lactate Solution for infusion for cattle, horses, dogs and cats [BE, FR, NL] INFUSOLEC solution for infusion for cattle, horses, dogs and cats [DE, DK, SE] 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1 ml dose contains: ACTIVE SUBSTANCES: Sodium (S)-Lactate 3.20 mg Sodium Chloride 6.00 mg Potassium Chloride 0.40 mg Calcium Chloride 0.20 mg (equivalent to Calcium Chloride Dihydrate: 0.27 mg) Sodium: 131 mmol/litre Potassium: 5 mmol/litre Calcium: 2 mmol/litre Bicarbonate (as lactate): 29 mmol/litre Chloride: 111 mmol/litre For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for infusion. Clear, colourless solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle, horses, dogs and cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES This veterinary medicinal product is administered by intravenous infusion for the treatment of dehydration and metabolic acidosis in cattle, horses, dogs and cats. It may be used to correct volume depletion (hypovolaemia) resulting from gastrointestinal disease or shock. 4.3 CONTRAINDICATIONS Do not use in animals with: - hyperkalaemia - hypercalcaemia - hypernatraemia - hyperlactataemia - hyperhydration - metabolic alkalosis - oedema (hepatic, renal, or cardiac) - Addison’s disease 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 3 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Do not use unless the solution is clear, free from visible particles, and the container is undamaged. A risk of thrombosis with intravenous infusion should be considered. Maintain aseptic precautions. This veterinary medicinal product should be warmed to approximately 37 o C prior to the administration of large volumes, or if the administration rate is high, in order to avoid hypothermia. This veterinary medicinal produ Read the complete document